A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs
Clinical trial NCT02720523 · COMPLETED
Trial details
- NCT number
- NCT02720523
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2017-08-03
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.